St. Jude Medical launches Ilumien Optis in Japan

March 12, 2013 by Brad Perriello

St. Jude Medical reveals the Japanese launch of its Ilumien Optis device, designed to indicate the state and severity of coronary lesions during stent procedures.

St. Jude Medical

St. Jude Medical (NYSE:STJ) said its launched the Ilumien Optis device in Japan, calling it the only medical device on the market to combine fractional flow reserve and optical coherence tomography technology to allow doctors to evaluate the state and severity of coronary lesions.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.